Skip to main content
. Author manuscript; available in PMC: 2011 Oct 12.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006690. doi: 10.1002/14651858.CD006690.pub2
Outcome or Subgroup Studies Participants Statistical Method Effect Estimate
8.1 Normalisation of fasting blood
glucose at trial completion (n) 		1 Risk Ratio ( IV , Random , 95% CI ) No totals
 8.1.1 Jinqi Jiangtang tablet 1 Risk Ratio ( IV , Random , 95% CI ) No totals
8.2 Incidence of diabetes (n) 1 Risk Ratio ( M-H , Random , 95% CI
)		 No totals
 8.2.1 Jinqi Jiangtang tablet 1 Risk Ratio ( M-H , Random , 95% CI
)		 No totals
8.3 Fasting blood glucose (mmol/L) 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
 8.3.1 06 Jinqi Jiangtang tablet 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
8.4 2hr fasting blood glucose
(mmol/L) [ after oral glucose
tolerance test] 		1 Mean Difference ( IV , Random ,
95% CI )		 No totals
 8.4.1 Jinqi Jiangtang tablet 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
8.5 Total cholesterol (mmol/L) 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
 8.5.1 Jinqi Jiangtang tablet 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
8.6 Trigylcerides (mmol/L) 1 Mean Difference ( IV , Random ,
95% CI )		 No totals
 8.6.1 Jinqi Jiangtang tablet 1 Mean Difference ( IV , Random ,
95% CI )		 No totals